CEISAM

Name

CEISAM

Legal name

Laboratoire CEISAM // CEISAM Institute – Chimie Et Interdisciplinarité : Synthèse, Analyse, Modélisation (UMR CNRS 6230)

Website

https://ceisam.univ-nantes.fr

Company type

Private

Founded year

2008

Operating status

Operating

Ownership category

akta.pro rank

Product category

Academic Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Material Characterization & Spectroscopy (NMR/FTIR/MS) (HLAGADAK)

Keywords

• Molecular chemistry research
• Analytical chemistry services
• Organic synthesis research
• NMR spectroscopy platform
• Public research laboratory

Headquarters

HQ city

Nantes

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Public research funding (ANR, ERC, PEPR): Government research grants from Agence Nationale de la Recherche (ANR), European Research Council (ERC) grants, and PEPR (Programmes et Équipements Prioritaires de Recherche). Currently hosting three ERC projects: DINAMIX, SUMMIT, and ATTOP.
2. Regional funding (Pays de la Loire): Co-financing from the Pays de la Loire region and European Union for platforms and equipment in NMR, Mass Spectrometry, Molecular Modeling, Optical spectroscopies and microscopy.
3. Public-private partnerships and contract research: Long-lasting partnerships with socio-economic players including small and medium businesses (spin-offs like Graftys, Atlanchim Pharma) and major international companies (Eurofins, Merck, Janssen, Sanofi, Servier) for collaborative research and technology transfer.
4. CIFRE doctoral grants: Industrial research contracts (CIFRE grants) co-financed with private companies for PhD research, e.g., CIFRE grant from Graftys (2020-2023).

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

CEISAM (UMR CNRS 6230) is a French public academic research laboratory conducting fundamental and applied research in molecular chemistry across three axes: synthesis of organic molecules and hybrid materials, methodological developments in analytical chemistry, and molecular modelling. The institute operates specialized equipment platforms (NMR, mass spectrometry, high-performance computing, optical spectroscopy, electrochemistry, isotope analysis) that provide analytical services to internal and external researchers. It also engages in public-private partnerships and contract research with pharmaceutical companies and SMEs, and supports technology transfer through spin-off creation.

Product overview

CEISAM Institute is a research institute (UMR CNRS 6230) focused on molecular chemistry, operating as a platform-based research infrastructure rather than a commercial product company. The institute provides access to specialized research platforms including the NMR Platform (largest in western France), AMaCC Platform for mass spectrometry and microcalorimetry, CHEM-Symbiose Platform for synthesis and molecular imaging, Plateforme Ligérienne d'Isotopie (regional isotope platform), High-Performance Computing Service, Electrochemistry, Analytical Equipment, Optical Spectroscopy, and Scientific Glassware Platform. These platforms support five research teams (CORAIL, IMF, MIMM, ModES, SYMBIOSE) conducting interdisciplinary chemistry research in synthesis, analysis, and molecular modeling across health, environment, and energy applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Analytical Equipment Comprehensive analytical instrumentation for chemical characterization and quantitative analysis available to research teams and external users.
• NMR Platform High-resolution liquid-state NMR platform, the largest in western France, comprising 6 high-field spectrometers and 3 benchtop spectrometers for structural and quantitative analysis. Provides analytical services to internal and external researchers.
• AMaCC Platform Analytical and Metrological Centre for Characterisation platform offering mass spectrometry services, microcalorimetry, equipment access, and research project support to academic and industrial researchers.
• CHEM-Symbiose Platform Platform for chemical synthesis, imaging, and vectorization research with specialized equipment and scientific animation services supporting therapeutic chemistry research.
• Plateforme Ligérienne d'Isotopie (PLI) Regional isotope platform from Pays de la Loire offering isotope analysis and research services to external academic and industrial researchers in the region.
• High-Performance Computing Service Computational resources for molecular modeling, simulation, and data analysis supporting all CEISAM research teams and external researchers.
• Electrochemistry Equipment Electrochemical instrumentation and expertise for redox chemistry studies and biosensor development, supporting research teams and external collaborations.
• Optical Spectroscopy Spectroscopic instrumentation for photophysical studies and photochemistry research supporting dye-sensitized solar cells, artificial photosynthesis, and MOFs research.
• Scientific Glassware Platform Custom glassware fabrication and specialized glass apparatus for laboratory research.

Quantifiable outcome

• Annual average of 120 scientific publications
• +4 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• GraftyscoreStrategic or Co-development PartnerPublic-private partnership with Graftys company (Nantes and Aix-en-Provence) for developing new generations of injectable calcium phosphate cements (CPCs) for bone therapies. Includes CIFRE doctoral grant (2020-2023) and collaborative R&D on CPCs combined with drugs, blood composites for intervertebral arthrodesis, and image-guided implantation.
• GuerbetminorStrategic or Co-development PartnerCollaboration in the calcium phosphate-based composites project for bone therapies, with Guerbet providing radiopaque contrast agent expertise.
• Société Colas SAminorStrategic or Co-development PartnerPartnership in the Algoroute project (2016-2020) and Bitume 2.0 project (2017-2020) for developing bio-binders from microalgae residues as substitutes for petroleum-based bitumen in road construction.
• O. Gauthier (ONIRIS, Nantes)minorStrategic or Co-development PartnerAcademic collaboration on calcium phosphate cement research for bone therapies, including in vivo studies and veterinary applications.
• Prof. Leif Hammarström (Uppsala University, Sweden)minorStrategic or Co-development PartnerLong-standing collaboration on time-resolved photophysical studies for dye-sensitized solar cells and artificial photosynthesis research.
• Prof. Eric Vauthey (Université de Genève)minorStrategic or Co-development PartnerCollaboration on photophysical investigations for p-type dye sensitized solar cells and artificial photosynthesis.
• Karlsruhe Institute of Technology (KIT) - Christoph Wöll groupminorStrategic or Co-development PartnerCollaboration on photoactive MOF thin films for solar energy conversion, including crystalline chromophore assemblies and excitonic coupling research.
• Ouest ValorisationminorImplementation/ SI/ Consulting PartnerTechnology transfer and intellectual property management partner for CEISAM research, supporting spin-off development and patent commercialisation.
• Prof. Marc Robert (LEM, Université de Paris)minorStrategic or Co-development PartnerCollaboration on photoelectrochemical cells for selective carbon dioxide reduction using molecular cobalt catalysts.
• Algosource TechnologiesminorStrategic or Co-development PartnerIndustrial partner in Algoroute project for supplying microalgae biomass residues for hydrothermal liquefaction to produce bio-binders.
• Christophe Blanquart (CRCINA, Nantes)minorStrategic or Co-development PartnerCollaboration on biological fate and impact of fluorescent organic nanoparticles for malignant pleural mesothelioma research.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Institut de Chimie Moléculaire et des Matériaux d'Orsay (ICMMO): UMR CNRS-Université Paris-Saclay chemistry research institute covering organic synthesis, analytical chemistry, and molecular modelling. Directly comparable to CEISAM in mission, structure, and research scope as a French public molecular chemistry laboratory.
• Institut de Chimie de Nice (ICN): CNRS UMR chemistry institute at Université Côte d'Azur with similar structure to CEISAM, covering organic chemistry, analytical chemistry, and molecular sciences with platform-based research infrastructure.
• Institut des Sciences Chimiques de Rennes (ISCR): CNRS UMR at University of Rennes covering molecular chemistry, materials chemistry, and theoretical chemistry. Comparable French public chemistry research institute with similar team structure and platform-based research model.
• Laboratoire de Chimie de Coordination (LCC): CNRS UMR at Toulouse focused on coordination chemistry, molecular catalysis, and materials. Sister CNRS chemistry laboratory with similar structure, ERC grant participation, and industry partnerships.
• Institut de Chimie des Substances Naturelles (ICSN): CNRS UMR dedicated to natural product chemistry at Université Paris-Saclay. Comparable French public chemistry research institute with focus on organic synthesis, biological chemistry, and platform-based research services.

Broad incumbents

• Eurofins Scientific: Global analytical testing services company that is both a CEISAM partner and a broader market participant in laboratory analytical services. Comparable as a high-scale operator leveraging analytical chemistry platforms for external clients.
• Symeres: European CRO/CDMO providing contract research and small-molecule development services. Comparable as a commercial counterpart that consumes advanced molecular chemistry capabilities similar to what CEISAM develops in-house.
• Charles River Laboratories: Global CRO providing analytical and laboratory services across pharmaceutical and life sciences. Comparable for the analytical services and contract research segments that overlap with CEISAM's platform-based offerings.

Emerging players

• Graftys: CEISAM spin-off commercializing injectable calcium phosphate cements for bone therapies. Comparable as a direct technology translation pathway of CEISAM research, with overlapping development teams and continued partnership.

Others

• Bureau de Recherches Géologiques et Minières (BRGM): French public geoscience institute with parallel structural characteristics to CEISAM as a government-funded research institute. Useful comparable for understanding public funding dynamics and institutional scale in French research landscape.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cassir-association
• Instagraminstagram.com/cassir.asso

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CEISAM